Local view for "http://purl.org/linkedpolitics/eu/plenary/2005-11-15-Speech-2-212"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2005-11-15"^^xsd:date2
dcterms:Is Part Of	lp_eu:REACH (Registration, Evaluation, Authorisation and Restriction of Chemicals)2
dcterms:Language	"nl"^^xsd:language2
lpv:document identification number	"en.20051115.25.2-212"2
lpv:hasSubsequent	lp_eu:2005-11-15-Speech-2-2132
lpv:speaker	lp:Dorette Corbey2
lpv:spokenAs	member; ENVI (2004-07-21--2007-01-14)3 unknown; Partij van de Arbeid (2004-07-20--2009-07-13)3 member; Delegation for relations with the People's Republic of China (2004-09-15--2007-03-13)3 member; PES (2004-07-20--2009-07-13)3 substitute; PECH (2005-09-08--2007-01-14)3 substitute; ITRE (2004-07-21--2007-01-14)3
lpv:translated text	"Mr President, I should first of all like to express my warm appreciation and thanks to Mr Sacconi who has, I think, done an excellent job. The REACH proposal means that 30 000 substances must be tested. As such, it is a source of innovation, but also of simplification. Since 40 directives will be withdrawn when REACH enters into effect, it will benefit both the environment and innovation. There are many fine amendments to make REACH more workable and less expensive, and to restrict the number of animal tests, but there are, unfortunately, still quite a few companies that are opposed to innovation and prefer to wallow in the unknown and do not feel like searching for safer and cleaner alternatives. Quite frankly, I think it is rather disappointing that they receive a good deal of political support. We all took up the challenge of Lisbon. Innovation is at the heart of European industry’s strong competitive position. Without continuing innovation to make products cleaner, safer and healthier, the European industry will end up losing out to China, India and the United States. The Dutch Social Democrats cannot back the compromise that is now before us. It represents a huge setback, if instead of 30 000 substances, only 8 000 are subjected to the full test regime of REACH, for then the uncertainty among consumers will remain, and the risk of allergies, cancer, and illnesses contracted at work will be perpetuated unnecessarily and potentially toxic substances will remain in the environment. Last but not least, with this, an incentive for continuing innovation in European industry is also being thrown overboard."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph